Sodium Phenylbutyrate (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Sodium Phenylbutyrate drug offered from Par Pharmaceutical, Inc.. This Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: Sodium Phenylbutyrate
SUBSTANCE NAME: SODIUM PHENYLBUTYRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: POWDER
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-08-31
END MARKETING DATE: 0000-00-00


Sodium Phenylbutyrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Phenylbutyrate from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.94(g/g)
START MARKETING DATE: 2016-08-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-006_4584c707-7c10-4c8d-8ed9-693cc576ac97
PRODUCT NDC: 49884-006
APPLICATION NUMBER: ANDA203918

Other SODIUM PHENYLBUTYRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Horizon Pharma, Inc.BUPHENYL
Mikart, Inc.sodium phenylbutyrate
Par Pharmaceutical, Inc.Sodium Phenylbutyrate
Sigmapharm Laboratories, LLCSodium Phenylbutyrate